Full View

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID‐19 patients: a retrospective cohort study

C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - Wiley Online Library
On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …
被引用次数：206 相关文章
[HTML] nih.gov

[HTML][HTML] The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Abstract On March 11, 2020, the World Health Organization declared its assessment of
coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

C Shi, C Wang, H Wang, C Yang, F Cai, F Zeng… - Clinical and …, 2020 - osti.gov
On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …
[HTML] europepmc.org

[HTML][HTML] The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study

C Shi, C Wang, H Wang, C Yang, F Cai, F Zeng… - 2020 - europepmc.org
Background On March 11, 2020, the World Health Organization declared its assessment of
COVID-19 as a global pandemic. However, specific antiviral drugs are still unavailable, and …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - cir.nii.ac.jp
抄録< jats: p> On March 11, 2020, the World Health Organization declared its assessment of
coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study

C Shi, C Wang, H Wang, C Yang… - Clinical and …, 2020 - pubmed.ncbi.nlm.nih.gov
On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID-19) as a global pandemic. However, specific anti-severe acute …

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study

C Shi, C Wang, H Wang, C Yang, F Cai, F Zeng… - medRxiv, 2020 - medrxiv.org
Summary Background On March 11, 2020, the World Health Organization declared its
assessment of COVID-19 as a global pandemic. However, specific antiviral drugs are still …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study

C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - diva-portal.org
On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID-19) as a global pandemic. However, specific anti-severe acute …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study.

C Shi, C Wang, H Wang, C Yang… - CTS: Clinical & …, 2020 - search.ebscohost.com
Abstract On March 11, 2020, the World Health Organization declared its assessment of
coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe …

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.

C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - europepmc.org
Abstract On March 11, 2020, the World Health Organization declared its assessment of
coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe …